BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17881433)

  • 1. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials.
    Martin JL; Sainz-Pardo M; Furukawa TA; Martín-Sánchez E; Seoane T; Galán C
    J Psychopharmacol; 2007 Sep; 21(7):774-82. PubMed ID: 17881433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of benzodiazepines: do they work or not?
    Lader M
    Expert Rev Neurother; 2008 Aug; 8(8):1189-91. PubMed ID: 18671662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.
    Offidani E; Guidi J; Tomba E; Fava GA
    Psychother Psychosom; 2013; 82(6):355-62. PubMed ID: 24061211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials.
    Rossano F; Caiazza C; Zotti N; Viacava L; Irano A; Solini N; Pistone L; Pezone R; Cilmi F; Ricci C; De Prisco M; Iasevoli F; Kishi T; Solmi M; de Bartolomeis A; Fornaro M
    Eur Neuropsychopharmacol; 2023 Nov; 76():23-51. PubMed ID: 37544075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    Lydiard RB; Rickels K; Herman B; Feltner DE
    Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis.
    Generoso MB; Trevizol AP; Kasper S; Cho HJ; Cordeiro Q; Shiozawa P
    Int Clin Psychopharmacol; 2017 Jan; 32(1):49-55. PubMed ID: 27643884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: Systematic review and meta-analysis.
    Gale C; Glue P; Guaiana G; Coverdale J; McMurdo M; Wilkinson S
    J Psychopharmacol; 2019 May; 33(5):543-547. PubMed ID: 30676225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety.
    Rickels K; Moeller HJ
    World J Biol Psychiatry; 2019 Sep; 20(7):514-518. PubMed ID: 30252578
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.
    Baldwin D; Woods R; Lawson R; Taylor D
    BMJ; 2011 Mar; 342():d1199. PubMed ID: 21398351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
    Gomez AF; Barthel AL; Hofmann SG
    Expert Opin Pharmacother; 2018 Jun; 19(8):883-894. PubMed ID: 29806492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.